The FDA has approved dupilumab to treat allergic fungal rhinosinusitis in adults and children ages 6 years and older.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/dupilumab-approved-allergic-fungal-rhinosinusitis-2026a10005zi?src=rss
Author :
Publish date : 2026-02-25 17:17:00
Copyright for syndicated content belongs to the linked Source.